Erythrocytosis, Familial, 3
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
1
|
3
|
0.700 |
strong |
1.000 |
2 |
3
|
2006 |
2007 |
Paraganglioma
|
disease |
Neoplasms
|
Neoplastic Process
|
165
|
36
|
0.380 |
strong |
1.000 |
9 |
|
2007 |
2019 |
Polycythemia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
82
|
22
|
0.360 |
strong |
1.000 |
7 |
1
|
2007 |
2016 |
Adrenal Gland Pheochromocytoma
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
416
|
50
|
0.350 |
strong |
0.833 |
6 |
|
2007 |
2015 |
Pheochromocytoma
|
disease |
Neoplasms
|
Neoplastic Process
|
344
|
186
|
0.330 |
strong |
0.750 |
4 |
|
2007 |
2015 |
Hereditary Paraganglioma-Pheochromocytoma Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms
|
Disease or Syndrome
|
23
|
98
|
0.300 |
moderate |
1.000 |
6 |
|
2006 |
2015 |
Encephalopathy, Toxic
|
disease |
Nervous System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
29
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Neurotoxicity Syndromes
|
group |
Nervous System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
34
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Toxic Encephalitis
|
disease |
Nervous System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
29
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Hypertensive disease
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
2322
|
1085
|
0.220 |
None |
1.000 |
3 |
|
2012 |
2017 |
Myocardial Infarction
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
1800
|
680
|
0.210 |
None |
1.000 |
2 |
|
2006 |
2013 |
Acute kidney injury
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Injury or Poisoning
|
185
|
3
|
0.200 |
None |
1.000 |
1 |
|
2009 |
2009 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
1.000 |
17 |
|
2006 |
2020 |
Hematocrit procedure
|
phenotype |
|
Laboratory Procedure
|
138
|
216
|
0.100 |
None |
1.000 |
1 |
2
|
2016 |
2016 |
Red Blood Cell Count measurement
|
phenotype |
|
Laboratory Procedure
|
717
|
1599
|
0.100 |
None |
1.000 |
1 |
3
|
2016 |
2016 |
Hemoglobin increased
|
phenotype |
Neoplasms; Hemic and Lymphatic Diseases
|
Finding
|
7
|
|
0.100 |
None |
|
0 |
|
|
|
Increased red blood cell mass
|
phenotype |
Hemic and Lymphatic Diseases
|
Finding
|
4
|
|
0.100 |
None |
|
0 |
|
|
|
Hematocrit increased
|
phenotype |
|
Finding
|
7
|
1
|
0.100 |
None |
|
0 |
|
|
|
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.090 |
None |
1.000 |
9 |
|
2010 |
2019 |
Erythrocytosis familial, 1
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
29
|
14
|
0.080 |
None |
0.875 |
8 |
1
|
2006 |
2012 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.080 |
None |
1.000 |
8 |
|
2012 |
2019 |
Familial erythrocytosis
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
17
|
2
|
0.080 |
None |
0.875 |
8 |
1
|
2006 |
2012 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.050 |
None |
1.000 |
5 |
|
2010 |
2019 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
0.040 |
None |
1.000 |
4 |
|
2010 |
2017 |
High altitude pulmonary edema
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
56
|
45
|
0.040 |
None |
1.000 |
4 |
1
|
2010 |
2015 |